NutraMax first quarter sales up 21.4% to $22 mil., paced by cough/cold products.
This article was originally published in The Tan Sheet
Executive Summary
NUTRAMAX SALES OF $22 MIL., UP 21.4%, PACED BY COUGH/COLD PRODUCTS in the first quarter of fiscal 1997 (ended Dec. 31), compared to $18.2 mil. in the year-ago period, the private label health and personal care products firm reported Jan. 20. "The company's strong performance in the quarter reflects record sales of cough/cold products...and double-digit increases for personal care, infant care and our ophthalmics product categories," NutraMax said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning